MARY OKIMOTO: Open Payments
NPI 1144400771 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 5 payments from 5 companies in 2025. Trend: 2023 $672 · 2024 $482 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 1 | $121 |
| Celgene Corporation | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
Products named: OPDIVO, IMBRUVICA, KEYTRUDA, Enhertu.
Industry payments across CA — which companies pay providers there.
